LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 42

Search options

  1. Article ; Online: Ancestromics.

    Fricke-Galindo, Ingrid / LLerena, Adrián

    Drug metabolism and personalized therapy

    2023  Volume 38, Issue 4, Page(s) 293

    Language English
    Publishing date 2023-12-07
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2822040-7
    ISSN 2363-8915 ; 2363-8907
    ISSN (online) 2363-8915
    ISSN 2363-8907
    DOI 10.1515/dmpt-2023-0089
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article ; Online: Ancestromics.

    Fricke-Galindo, Ingrid / LLerena, Adrián

    Drug metabolism and personalized therapy

    2023  

    Language English
    Publishing date 2023-12-07
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2822040-7
    ISSN 2363-8915 ; 2363-8907
    ISSN (online) 2363-8915
    ISSN 2363-8907
    DOI 10.1515/dmdi-2023-0089
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Article ; Online: Relevance of personalized medicine for improving traditional medicine.

    Fricke-Galindo, Ingrid / LLerena, Adrián

    Drug metabolism and personalized therapy

    2023  

    Language English
    Publishing date 2023-08-24
    Publishing country Germany
    Document type Editorial
    ZDB-ID 2822040-7
    ISSN 2363-8915 ; 2363-8907
    ISSN (online) 2363-8915
    ISSN 2363-8907
    DOI 10.1515/dmdi-2023-0068
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  4. Article ; Online: Relevance of personalized medicine for improving traditional medicine.

    Fricke-Galindo, Ingrid / LLerena, Adrián

    Drug metabolism and personalized therapy

    2023  Volume 38, Issue 3, Page(s) 209–210

    MeSH term(s) Humans ; Precision Medicine
    Language English
    Publishing date 2023-08-24
    Publishing country Germany
    Document type Editorial
    ZDB-ID 2822040-7
    ISSN 2363-8915 ; 2363-8907
    ISSN (online) 2363-8915
    ISSN 2363-8907
    DOI 10.1515/dmpt-2023-0068
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  5. Article ; Online: News in DMPT: Leaders in Pharmacogenetics Section.

    Fricke-Galindo, Ingrid / LLerena, Adrián

    Drug metabolism and personalized therapy

    2023  Volume 38, Issue 1, Page(s) 1–2

    MeSH term(s) Humans ; Pharmacogenetics ; Sulfonium Compounds
    Chemical Substances dimethylpropiothetin (C884XA7QGG) ; Sulfonium Compounds
    Language English
    Publishing date 2023-02-20
    Publishing country Germany
    Document type Editorial
    ZDB-ID 2822040-7
    ISSN 2363-8915 ; 2363-8907
    ISSN (online) 2363-8915
    ISSN 2363-8907
    DOI 10.1515/dmpt-2023-0004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  6. Article ; Online: Exploring the potential benefits of pharmacogenomics in chronic respiratory diseases.

    Fricke-Galindo, Ingrid / Falfán-Valencia, Ramcés

    Pharmacogenomics

    2023  Volume 24, Issue 5, Page(s) 239–241

    Abstract: Tweetable abstract Opportunities for pharmacogenetics implementation in chronic respiratory diseases through the employment of genotype-guided prescriptions in treating nonrespiratory comorbidities. ...

    Abstract Tweetable abstract Opportunities for pharmacogenetics implementation in chronic respiratory diseases through the employment of genotype-guided prescriptions in treating nonrespiratory comorbidities.
    MeSH term(s) Humans ; Pharmacogenetics ; Genotype ; Respiratory Tract Diseases/drug therapy ; Respiratory Tract Diseases/genetics
    Language English
    Publishing date 2023-04-04
    Publishing country England
    Document type Editorial
    ZDB-ID 2019513-8
    ISSN 1744-8042 ; 1462-2416
    ISSN (online) 1744-8042
    ISSN 1462-2416
    DOI 10.2217/pgs-2023-0036
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 5247: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  7. Article ; Online: Current pharmacogenomic recommendations in chronic respiratory diseases: Is there a biomarker ready for clinical implementation?

    Fricke-Galindo, Ingrid / Falfán-Valencia, Ramcés

    Expert review of respiratory medicine

    2022  Volume 16, Issue 11-12, Page(s) 1145–1152

    Abstract: Introduction: The study of genetic variants in response to different drugs has predominated in fields of medicine such as oncology and infectious diseases. In chronic respiratory diseases, the available pharmacogenomic information is scarce but not less ...

    Abstract Introduction: The study of genetic variants in response to different drugs has predominated in fields of medicine such as oncology and infectious diseases. In chronic respiratory diseases, the available pharmacogenomic information is scarce but not less relevant.
    Areas covered: We searched the pharmacogenomic recommendations for respiratory diseases in the Table of Pharmacogenomic Biomarkers in Drug Labeling (U.S. Food and Drug Administration), the Clinical Pharmacogenomics Implementation Consortium (CPIC), and PharmGKB. The main pharmacogenomics recommendation in this field is to assess
    Expert opinion: The pharmacogenomics recommendations for lung diseases are limited. The clinical implementation of pharmacogenomics in treating respiratory diseases will contribute to the quality of life of patients with chronic respiratory diseases.
    MeSH term(s) Humans ; Pharmacogenetics ; Quality of Life ; Biomarkers
    Chemical Substances Biomarkers
    Language English
    Publishing date 2022-11-23
    Publishing country England
    Document type Journal Article
    ZDB-ID 2479146-5
    ISSN 1747-6356 ; 1747-6348
    ISSN (online) 1747-6356
    ISSN 1747-6348
    DOI 10.1080/17476348.2022.2149496
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 6963: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  8. Article ; Online: Genetics Insight for COVID-19 Susceptibility and Severity: A Review.

    Fricke-Galindo, Ingrid / Falfán-Valencia, Ramcés

    Frontiers in immunology

    2021  Volume 12, Page(s) 622176

    Abstract: Coronavirus disease (COVID-19) presents a broad spectrum of clinical manifestations ranging from an asymptomatic to a severe clinical course. The host genetic background influence on the susceptibility and outcome of multiples infectious diseases has ... ...

    Abstract Coronavirus disease (COVID-19) presents a broad spectrum of clinical manifestations ranging from an asymptomatic to a severe clinical course. The host genetic background influence on the susceptibility and outcome of multiples infectious diseases has been previously reported. Herein, we aimed to describe relevant identified genetic variants and those potentially related to the inter-individual variability of COVID-19 susceptibility and/or severity considering the physiopathological pathway of the disease The
    MeSH term(s) Alleles ; COVID-19/genetics ; COVID-19/immunology ; Gene Expression Regulation ; Genetic Predisposition to Disease ; Genetic Variation ; Humans ; SARS-CoV-2/genetics ; SARS-CoV-2/immunology
    Language English
    Publishing date 2021-04-01
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2021.622176
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  9. Article ; Online: Pharmacogenetics Approach for the Improvement of COVID-19 Treatment.

    Fricke-Galindo, Ingrid / Falfán-Valencia, Ramcés

    Viruses

    2021  Volume 13, Issue 3

    Abstract: The treatment of coronavirus disease 2019 (COVID-19) has been a challenge. The efficacy of several drugs has been evaluated and variability in drug response has been observed. Pharmacogenetics could explain this variation and improve patients' outcomes ... ...

    Abstract The treatment of coronavirus disease 2019 (COVID-19) has been a challenge. The efficacy of several drugs has been evaluated and variability in drug response has been observed. Pharmacogenetics could explain this variation and improve patients' outcomes with this complex disease; nevertheless, several disease-related issues must be carefully reviewed in the pharmacogenetic study of COVID-19 treatment. We aimed to describe the pharmacogenetic variants reported for drugs used for COVID-19 treatment (remdesivir, oseltamivir, lopinavir, ritonavir, azithromycin, chloroquine, hydroxychloroquine, ivermectin, and dexamethasone). In addition, other factors relevant to the design of pharmacogenetic studies were mentioned. Variants in
    MeSH term(s) Animals ; Antiviral Agents/administration & dosage ; COVID-19/drug therapy ; COVID-19/genetics ; COVID-19/virology ; Humans ; Pharmacogenetics ; Pharmacogenomic Variants ; SARS-CoV-2/drug effects ; SARS-CoV-2/genetics ; SARS-CoV-2/physiology
    Chemical Substances Antiviral Agents
    Language English
    Publishing date 2021-03-05
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v13030413
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  10. Article: Pharmacogenetics Approach for the Improvement of COVID-19 Treatment

    Fricke-Galindo, Ingrid / Falfán-Valencia, Ramcés

    Viruses. 2021 Mar. 05, v. 13, no. 3

    2021  

    Abstract: The treatment of coronavirus disease 2019 (COVID-19) has been a challenge. The efficacy of several drugs has been evaluated and variability in drug response has been observed. Pharmacogenetics could explain this variation and improve patients’ outcomes ... ...

    Abstract The treatment of coronavirus disease 2019 (COVID-19) has been a challenge. The efficacy of several drugs has been evaluated and variability in drug response has been observed. Pharmacogenetics could explain this variation and improve patients’ outcomes with this complex disease; nevertheless, several disease-related issues must be carefully reviewed in the pharmacogenetic study of COVID-19 treatment. We aimed to describe the pharmacogenetic variants reported for drugs used for COVID-19 treatment (remdesivir, oseltamivir, lopinavir, ritonavir, azithromycin, chloroquine, hydroxychloroquine, ivermectin, and dexamethasone). In addition, other factors relevant to the design of pharmacogenetic studies were mentioned. Variants in CYP3A4, CYP3A5, CYP2C8, CY2D6, ABCB1, ABCC2, and SLCO1B1, among other variants, could be included in pharmacogenetic studies of COVID-19 treatment. Besides, nongenetic factors such as drug–drug interactions and inflammation should be considered in the search for personalized therapy of COVID-19.
    Keywords COVID-19 infection ; azithromycin ; chloroquine ; dexamethasone ; inflammation ; ivermectin ; oseltamivir ; pharmacogenomics ; therapeutics
    Language English
    Dates of publication 2021-0305
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    Note NAL-light
    ZDB-ID 2516098-9
    ISSN 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v13030413
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top